Open AccessAbsolute Increase in the Number and Proportion of Peripheral Eosinophils Associated With Immune Checkpoint Inhibitor Treatment in Non-small Cell Lung Cancer Patients
Author(s) -
Hajime Osawa,
Toshihiro Shiozawa,
Shinichiro Okauchi,
Yuika Sasatani,
Gen Ohara,
Shinya Sato,
Kunihiko Miyazaki,
Takahide Kodama,
Katsunori Kagohashi,
Hiroaki Satoh,
Nobuyuki Hizawa
Publication year - 2021
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10065
Subject(s) - discontinuation , medicine , peripheral , adverse effect , chemotherapy , immune system , lung cancer , eosinophil , cancer , gastroenterology , oncology , immunology , asthma
To clarify the clinical significance of the absolute increase in the number and proportion of peripheral eosinophils associated with immune checkpoint inhibitor (ICPI) treatment in non-small cell lung cancer (NSCLC) patients.